Neuspera Medical Announces Milestone Case of Traditional SNM System Replacement

Patient with urinary urge incontinence receives Neuspera's integrated SNM system, reporting full complication relief

Published on Feb. 10, 2026

Got story updates? Submit your updates here. ›

Neuspera Medical, a developer of integrated neuromodulation technologies, announced a milestone patient revision from a traditional sacral neuromodulation (SNM) system to the company's recently FDA-approved integrated SNM (iSNM) system. The patient, a 21-year-old woman, experienced persistent battery discomfort and lead issues after receiving a conventional SNM implant, and a prior surgical revision did not improve her symptoms. After receiving the Neuspera iSNM system, the patient experienced immediate and complete complication relief, according to her surgeon.

Why it matters

Traditional SNM systems have notable downsides, including the need for implanted lithium-ion batteries that can lead to pocket pain, infections, lead migration, and fractures. These complications impact patient quality of life and drive substantial healthcare costs, with revisions and replacements accounting for up to 30% of total SNM-related procedures. Neuspera's integrated SNM system aims to address these common issues without compromising performance.

The details

The revision surgery was performed at University of Louisville Health in Kentucky. The Neuspera iSNM system features a smart, miniaturized neurostimulator carefully implanted near the sacral nerve, and therapy is activated using an external disc with a battery worn against the lower back for approximately two hours daily. This eliminates the need for implanted batteries, addressing common patient concerns. A pivotal study of 128 patients found that 91% of trial period responders achieved at least 50% reduction in urgent leaks at six months, and 84% were classified as "super responders" with at least 75% improvement.

  • The revision surgery was performed in February 2026.
  • Neuspera's iSNM system was FDA-approved in June 2025.

The players

Neuspera Medical, Inc.

The leading developer of integrated technologies powering the future of neuromodulation.

University of Louisville Health (UofL Health)

The healthcare system where the revision surgery was performed.

Dr. Kellen Choi

The treating urologist at UofL Health who performed the revision surgery.

Dave Van Meter

The chief executive officer of Neuspera Medical.

Got photos? Submit your photos here. ›

What they’re saying

“I was in constant pain from the SNM battery and calling my doctor's office often. They tried an initial revision with another SNM battery device, and it still made no difference. Pain was negatively affecting my quality of life and making it even hard to get out of bed. After I received the Neuspera iSNM device, I couldn't believe the difference. The pain is gone, and I finally have my life back! And now my doctor's office is calling me to check in, because it's so strange that they haven't heard from me.”

— Patient

“This case demonstrates the impact of Neuspera's integrated design, resolving pain and complications associated with traditional SNM implanted batteries. It's rewarding to see patients regain their freedom and confidence so quickly, substantially improving their quality of life. In addition to the many patients who have not had any advanced treatment for their UUI, we also have many more patients in line who have these common complications of traditional SNM who would like to pursue this new option with no trade-off whatsoever in efficacy.”

— Dr. Kellen Choi, Treating Urologist, UofL Health

“This case at UofL Health exemplifies how our design, free of implanted batteries, can restore freedom and confidence for patients limited by traditional SNM. By addressing these common complications linked to conventional devices, Neuspera is offering an improved option and empowering individuals to reclaim control over their lives.”

— Dave Van Meter, Chief Executive Officer, Neuspera Medical

What’s next

Neuspera is launching the FREEDOM Registry (Follow-up Revision Experience and Evaluation: Device Outcomes Metrics) to gather patient-reported data on experiences, quality of life, pain relief, and satisfaction among people who switch from traditional SNM to Neuspera's iSNM system.

The takeaway

Neuspera's integrated SNM system addresses the common complications associated with traditional SNM devices, such as implanted battery issues, without compromising efficacy. This milestone case demonstrates the potential for Neuspera's technology to improve quality of life for patients struggling with urinary urge incontinence.